Month: July 2025
European Union in limbo as Washington keeps it waiting on a trade agreement
The European Union (EU) is stuck in limbo as uncertainty persists around when a trade agreement with the U.S. might be reached. The goal had been to agree on a framework by July 9, when a temporary reprieve from U.S. President Donald Trump’s “reciprocal” tariffs was initially meant to expire. The EU was seemingly still […]
Read More
Stocks making the biggest moves premarket: Starbucks, AES, Verona Pharma, UnitedHealth & more
Check out the companies making headlines before the opening bell: Starbucks – Shares of the coffee chain jumped almost 2% after CNBC reported that Starbucks China has drawn bids for a potential stake sale that value the subsidiary at up to $10 billion. While shortlisting could be done in two months, the deal itself likely […]
Read More
BNY Mellon will have custody of Ripple’s new stablecoin as institutional interest in crypto swells
Jakub Porzycki | Nurphoto | Getty Images Bank of New York Mellon will be the primary custodian for the Ripple’s U.S. dollar-pegged stablecoin reserves going forward, the two companies said Wednesday. The partnership should enhance regulatory compliance for Ripple, the issuer of ripple USD (RLUSD), and boost institutional credibility for the company as well as […]
Read More
Vanguard, BlackRock deliver second-half market plays that could cushion a potential growth slowdown
ETF Edge Vanguard, BlackRock deliver second-half market plays that could cushion a potential growth slowdown Published Wed, Jul 9 20257:30 AM EDT Siena Griffin@siena_griffin WATCH LIVE Source
Read More
Merck shells out $10 billion for London-based lung therapy firm Verona
Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]
Read More
Singapore state investor Temasek is rethinking defense as a strategic ESG bet
Defense stocks are booming — and according to one of Asia’s biggest investors, allocating capital to the sector doesn’t mean having to abandon ESG initiatives. Speaking to CNBC’s Martin Soong on Wednesday, Rohit Sipahimalani, chief investment officer at Singapore’s state investment fund Temasek, said his team were looking at opportunities in the European defense sector. […]
Read More
Temasek’s portfolio scales new peak even as divestments hit over 2-decade high
An undated photo of a signage at Singapore state investor Temasek Holdings’ headquarters in the Southeast Asian city-state. Bryan van der Beek | Bloomberg | Getty Images Singapore state investment company Temasek Holdings’ net portfolio value soared to a record high of 434 billion Singapore dollars ($324 billion) for its financial year ended March. That’s […]
Read More
Trump’s tariffs on cars, copper, drugs, aluminum could hit harder than other levies
U.S. President Donald Trump walks as workers react at U.S. Steel Corporation–Irvin Works in West Mifflin, Pennsylvania, U.S., May 30, 2025. Leah Millis | Reuters As President Donald Trump’s tariffs against more than a dozen countries spark fresh concerns about looming country-specific trade measures, often overlooked are the levies on specific products and commodities that […]
Read More
CNBC’s The China Connection newsletter: The hidden drag on China’s economy
Pictured here is construction on the One Sunac Opus high-end apartment complex in Beijing on Oct. 17, 2024. Bloomberg | Bloomberg | Getty Images This report is from this week’s CNBC’s The China Connection newsletter, which brings you insights and analysis on what’s driving the world’s second-largest economy. Each week, we’ll explore the biggest business […]
Read More